Catalytic enantioselective synthesis of the phosphodiesterase type IV inhibitor (R)-(-)-rolipram via intramolecular C-H insertion process

Synlett

Volumn , Issue 11, 1999, Pages 1775-1777

  Anada, Masahiro ^a   Mita, Orie ^a   Watanabe, Hiroko ^a   Kitagaki, Shinji ^a   Hashimoto, Shunichi ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

(R) ( ) rotipram; C H insertion; Chiral dirhodium(II) catalyst; Enantioselective synthesis; Phosphodiesterase inhibitor

Indexed keywords

PHOSPHODIESTERASE INHIBITOR; RHODIUM; ROLIPRAM;

ARTICLE; CATALYSIS; CATALYST; CHEMICAL REACTION; CHEMICAL STRUCTURE; CHIRALITY; DRUG SYNTHESIS; ENANTIOMER;

EID: 0032726846     PISSN: 09365214     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-1999-2958     Document Type: Article

References (33)

1. (a) Wachtel, H. J. Pharm. Pharmacol. 1983, 35, 440.
2. (b) Schneider, H. H.; Schmiechen, R.; Brezinski, M.; Seidler, J. Eur. J. Pharmacol. 1986, 127, 105.
3. Beavo, J. A.; Reifsnyder, D. H. Trends Pharm. Sci. 1990, 11, 150.
4. (a) Giembycz, M. A.; Dent, G. Clin. Exp. Allergy 1992, 22, 337.
5. (b) Torphy, T. J.; Livi, G. P.; Christensen, S. B. Drug News Perspect. 1993, 6, 203.
6. Klein-Tebbe, J.; Wicht, H.; Gagné, L.; Friese, A.; Schunack, W.; Schudt, C.; Kunkel, G. Agent Actions 1992, 36, 200.
7. Dinter, H.; Onuffer, J.; Faulds, D.; Perez, H. D. J. Mol. Med. 1997, 75, 95.
8. (a) Zeller, E.; Stief, H. J.; Pflung, B.; Sastre, Y.; Hernandez, M. Pharmacopsychiatry 1984, 17, 188.
9. (b) Duplantier, A. J.; Biggers, M. S.; Chambers, R. J.; Cheng, J. B.; Cooper, K.; Damon, D. B.; Eggler, J. F.; Kraus, K. G.; Marfat, A.; Masamune, H.; Pillar, J. S.; Shirley, J. T.; Umland, J. P.; Watson, J. W. J. Med. Chem. 1996, 39, 120.
10. (a) Pinto, I. L.; Buckle, D. R.; Readshaw, S. A.; Smith, D. G. Bioorg. Med. Chem. Lett. 1993, 3, 1743.
11. (b) Masamune, H.; Cheng, J. B.; Cooper, K.; Eggler, J. F.; Marfat, A.; Marshall, S. C.; Shirley, J. T.; Tickner, J. E.; Umland, J. P.; Vazquez, E. Bioorg. Med. Chem. Lett. 1995, 5, 1965.
12. (c) Cheng, J. B.; Cooper, K.; Duplantier, A. J.; Eggler, J. F.; Kraus, K. G.; Marshall, S. C.; Marfat, A.; Masamune, H.; Shirley, J. T.; Tickner, J. E.; Umland, J. P. Bioorg. Med. Chem. Lett. 1995, 5, 1969.
13. Baures, P. W.; Eggleston, D. S.; Erhard, K. F.; Cieslinski, L. B.; Torphy, T. J.; Christensen, S. B. J. Med. Chem. 1993, 36, 3274.
14. For a review on asymmetric synthesis of (R)-(-)-rolipram, see; Mulzer, J. J. Prakt. Chem. 1994, 336, 287.
15. Mulzer, J.; Zuhse, R.; Schmiechen, R. Angew. Chem. Int. Ed. Engl. 1992, 31, 870.
16. Meyers, A. I.; Snyder, L. J. Org. Chem. 1993, 58, 36.
17. Diaz, A.; Siro, J. G.; García-Navío, J. L.; Vaquero, J. J.; Alvarez-Builla J. Synthesis 1997, 559.
18. Langlois, N.; Wang, H.-S. Synth. Commun. 1997, 27, 3133.
19. Braun, M.; Opdenbusch, K.; Unger, C. Synlett 1995, 1174.
20. Honda, T.; Ishikawa, F.; Kanai, K.; Sato, S.; Kato, D.; Tominaga, H. Heterocycles 1996, 42, 109.
21. Anada, M.; Hashimoto, S. Tetrahedron Lett. 1998, 39, 79.
22. Butterick, J. R.; Unrau, A. H. J. Chem. Soc., Chem. Commun. 1974, 307.
23. 13C NMR), analytical, and/or high-resolution mass spectral characteristics.
24. Lantz, R.; Obellianne, P. Bull. Soc. Chim. Fr. 1956, 311.
25. Davies, H. M. L.; Cantrell, W. R., Jr.; Romines, K. R.; Baum, J. S. Org. Synth. 1992, 70, 93.
26. Koteswar Rao, Y.; Nagarajan, M. J. Org. Chem. 1989, 54, 5678.
27. Kitagaki, S.; Anada, M.; Kataoka, O.; Matsuno, K.; Umeda, C.; Watanabe, N.: Hashimoto, S. J. Am. Chem. Soc. 1999, 121, 1417.
28. 3 which exhibited the methoxy signals of the 3S,4R and 3R,4S enantiomers at δ 4.01 and 3.92, respectively.
29. Krapcho, A. P. Synthesis 1982, 805; 893.
30. Separation conditions: 10% i-PrOH in hexane as an eluent; flow rate: 1.5 mL/min; retention time: 26.0 min [(4S)-9] and 31.5 min [(4R)-9].
31. Owsley, D. C.; Bloomfield, J. J. Synthesis 1977, 118.
32. Fukase, K.; Yasukochi, T.; Nakai, Y.; Kusumoto, S. Tetrahedron Lett. 1996, 37, 3343.
33. Jacob, P., III; Callery, P. S.; Shulgin, A. T.; Castagnoli, N., Jr. J. Org. Chem. 1976, 41, 3627.